Cytokinetics (CYTK) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.35 --0%
Revenue Growth %: +1,960.6%
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: +1,960.6%
Financial Fact:
Operating loss: 32.49M
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q2 EPS of ($0.60), $0.03 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $8.33 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
